31, 2015. Canaglifozin (Invokana) tablets, to improve glycemic control in adults with type 2 diabetes, along with diet and exercise. ... It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment or end-stage
The prospective InterAct case-cohort study conducted in 26 centers in eight European countries, is investigating how genetics and lifestyle interact to affect diabetes risk. ... Waist circumference is just as important as other risk factors for diabetes
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a ... Empagliflozin (Jardiance) to treat type 2
The FDA continues to investigate and has not determined whether the diabetes drug increases the risk of leg and foot amputations.
population. In addition, they have high rates of type 2 diabetes, cardiovascular disease, substance abuse, tuberculosis and accidents. ... Hospital. “These volunteers have helped us to develop diabetes treatment protocols, something that we would not
This patient most likely has new-onset type 2 diabetes mellitus (recent-onset polyuria and nocturia, high random glucose levels) and classic features of excess mineralocorticoid activity, including hypertension, metabolic alkalosis, ... Adrenal adenomas
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) to improve glucose control in adults with diabetes. ... The former agent, a long-acting insulin analog for both type 1 and 2 diabetes, is subcutaneously
For diabetes mellitus, the following information will be needed: type of diabetes (i.e., due to underlying condition, chemical- or drug-induced, type 1, type 2); body system affected; complication or ... manifestation; and, for type 2 diabetes, whether
of the time in patients with diseases that internists commonly see and treat—heart disease, diabetes and inflammatory disorders. ... Our scores were abysmal, and we started with diabetes because we knew that 30% of those patients have depression,” Dr.
Why have you been having such a hard time lately controlling your diabetes?” I asked. ... My patient really did want to control his diabetes, but was very much prevented from doing so by his inability to swallow large pills.